Vanguard Personalized Indexing Management
PRME icon

Vanguard Personalized Indexing Management’s Prime Medicine PRME Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.1K Sell
20,083
-1,871
-9% -$6.21K ﹤0.01% 2091
2026
Q1 		$76.4K Sell
21,954
-1,697
-7% -$6.46K ﹤0.01% 1994
2025
Q4 		$82.1K Sell
23,651
-333
-1% -$1.48K ﹤0.01% 1835
2025
Q3 		$133K Buy
23,984
+793
+3% +$3.22K ﹤0.01% 1773
2025
Q2 		$57.3K Buy
23,191
+7,954
+52% +$12.3K ﹤0.01% 1810
2025
Q1 		$30.3K Buy
15,237
+2,859
+23% +$7.29K ﹤0.01% 1728
2024
Q4 		$36.1K Buy
+12,378
New +$43.4K ﹤0.01% 1727

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Personalized Indexing Management's PRME Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Prime Medicine (PRME) stake by 8.5% in Q2 2026, selling an estimated $6.21K and leaving 20,083 shares worth $74.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

Vanguard Personalized Indexing Management first reported a position in PRME in Q4 2024 and has held it in 7 quarters since. The position peaked at $133K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Vanguard Personalized Indexing Management held 20,083 shares of Prime Medicine worth $74.1K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,871 Prime Medicine shares in Q2 2026, an estimated $6.21K.
  • Prime Medicine made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2091 holding.
  • Vanguard Personalized Indexing Management first reported a position in Prime Medicine in Q4 2024 and has held it in 7 quarters since.
  • Vanguard Personalized Indexing Management's Prime Medicine position peaked at $133K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.